GlassScriptPhysician profile
Ronald Paasch
NPI 1609834670
$1,497.45
in general payments reported to CMS, 2019-2025
28 companies · $208 in 2025
The $208 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $565 · 2020: $131 · 2021: $107 · 2022: $46.66 · 2023: $129 · 2024: $310 · 2025: $208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $648.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $647.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $337.20 | 2019-2025 | |
| Assertio Therapeutics, INC. | $154.68 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $97.41 | 2019-2020 | |
| Allergan, INC. | $85.88 | 2019-2021 | |
| Fidia Pharma USA INC. | $79.87 | 2019-2020 | |
| Painteq LLC | $70.84 | 2024 | Painteq |
| Medtronic, INC. | $69.99 | 2021-2025 | Intellis Adaptivestim, Inceptiv |
| Lundbeck LLC | $49.13 | 2024-2025 | Vyepti |
| Pfizer INC. | $45.98 | 2019-2020 | |
| Azurity Pharmaceuticals, INC. | $45.84 | 2025 | Horizant |
| Arbor Pharmaceuticals, INC. | $39.30 | 2019-2021 | |
| Nevro Corp. | $37.92 | 2024 | Senza |
| Pacira Therapeutics, INC. | $35.17 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $34.03 | 2024 | Iovera, Zilretta |
| Bioventus LLC | $32.38 | 2019-2023 | Durolane |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tersera Therapeutics LLC | $29.80 | 2019 | |
| Amgen INC. | $29.03 | 2019 | |
| Si-Bone, INC. | $28.86 | 2021 | |
| Biodelivery Sciences International, INC. | $28.67 | 2019-2020 | |
| Averitas Pharma INC. | $24.45 | 2023 | Qutenza |
| Relievant Medsystems, INC. | $24.45 | 2022 | |
| Radius Health, INC. | $23.19 | 2019 | |
| Abbott Laboratories | $18.04 | 2019 | |
| Spinal Simplicity, LLC | $17.30 | 2025 | Ha Minuteman G3-R |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.37 | 2019 | |
| Daiichi Sankyo INC. | $15.26 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $14.16 | 2025 | |
| Sentynl Therapeutics, INC. | $12.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Paasch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.